Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic...
Dr Gwenaëlle Gravis - Institut Paoli-Calmettes, Marseilles, France
Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer ( Dr Gwenaëlle Gravis - Institut Paoli-Calmettes, Marseilles, France )
28 Feb 2015
Combination of abiraterone and cabazitaxel in metastatic castration-resistant...
Dr Joaquin Mateo - Institute of Cancer Research, London, UK
Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer ( Dr Joaquin Mateo - Institute of Cancer Research, London, UK )
27 Feb 2015
Is there a role for androgen deprivation therapy combined with radiotherapy in...
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Is there a role for androgen deprivation therapy combined with radiotherapy in intermediate risk prostate cancer? ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
27 Feb 2015
When and whether to conduct endocrine therapy in non-metastatic prostate cancer
Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark
When and whether to conduct endocrine therapy in non-metastatic prostate cancer ( Dr Frederik Birkebæk Thomsen - University of Copenhagen, Copenhagen, Denmark )
27 Feb 2015
ASCO GU 2015: Prostate highlights from day one
Prof Karim Fizazi, Prof Kurt Miller, Dr Maria De Santis, Dr Mark Rubin
ASCO GU 2015: Prostate highlights from day one ( Prof Karim Fizazi, Prof Kurt Miller, Dr Maria De Santis, Dr Mark Rubin )
26 Feb 2015
Metastatic prostate cancer - Interpreting negative trial results
Prof Stephane Oudard and Prof Noel Clarke
Metastatic prostate cancer - Interpreting negative trial results ( Prof Stephane Oudard and Prof Noel Clarke )
26 Feb 2015
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity...
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Understanding PC heterogeneity to guide treatment choices ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Welcome and introduction
Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium
Optimizing survival in advanced prostate cancer: Welcome and introduction ( Dr Bertrand Tombal – Saint-Luc Hospital, Brussels, Belgium )
29 Jan 2015
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to...
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
29 Jan 2015
Optimizing survival in advanced prostate cancer: CHAARTED: What are the...
Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Optimizing survival in advanced prostate cancer: CHAARTED: What are the implications for the future? ( Prof Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )
29 Jan 2015
Advances in prostate cancer - Expert discussion
Prof Kurt Miller, Dr Heather Payne, Dr Maria de Santis, Prof Frédéric Lecouvet
Advances in prostate cancer - Expert discussion ( Prof Kurt Miller, Dr Heather Payne, Dr Maria de Santis, Prof Frédéric Lecouvet )
23 Jan 2015
Hormone receptor function in breast cancer therapy
Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The...
Hormone receptor function in breast cancer therapy ( Dr Wilbert Zwart, Netherlands Cancer Instititute (NKI), Amsterdam, The Netherlands )
6 Jan 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation